GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinogen Medical Ltd (ASX:ACW) » Definitions » Institutional Ownership

Actinogen Medical (ASX:ACW) Institutional Ownership : 0.00% (As of Jun. 09, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Actinogen Medical Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Actinogen Medical's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Actinogen Medical's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Actinogen Medical's Float Percentage Of Total Shares Outstanding is 0.00%.


Actinogen Medical Institutional Ownership Historical Data

The historical data trend for Actinogen Medical's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actinogen Medical Institutional Ownership Chart

Actinogen Medical Historical Data

The historical data trend for Actinogen Medical can be seen below:

2023-01-31 2023-02-28 2023-03-31 2023-04-30 2023-05-31 2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31
Institutional Ownership 1.35 1.37 1.37 1.39 1.41 1.09 0.56 0.55 0.01 0.01

Actinogen Medical Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Actinogen Medical (ASX:ACW) Business Description

Traded in Other Exchanges
Address
109 Pitt Street, Level 9, Suite 901, Sydney, NSW, AUS, 2000
Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. Geographically, it operates and derives revenue from Australia. It has developed a product Xanamem.

Actinogen Medical (ASX:ACW) Headlines

From GuruFocus

Stocks That Are Making A Good Come Back

By reports.droy reports.droy 03-10-2015

Accuride Corporation: Earnings Report For Q2 2014

By Black Iguana Nitish 10-13-2014